HK1153267A1 - Methods and compositions for diagnosis and prognosis of renal injury and renal failure - Google Patents
Methods and compositions for diagnosis and prognosis of renal injury and renal failureInfo
- Publication number
- HK1153267A1 HK1153267A1 HK11107246.4A HK11107246A HK1153267A1 HK 1153267 A1 HK1153267 A1 HK 1153267A1 HK 11107246 A HK11107246 A HK 11107246A HK 1153267 A1 HK1153267 A1 HK 1153267A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- renal
- prognosis
- diagnosis
- compositions
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4745—Insulin-like growth factor binding protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/795—Porphyrin- or corrin-ring-containing peptides
- G01N2333/80—Cytochromes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9291808P | 2008-08-29 | 2008-08-29 | |
US9292108P | 2008-08-29 | 2008-08-29 | |
PCT/US2009/055460 WO2010025434A1 (en) | 2008-08-29 | 2009-08-28 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1153267A1 true HK1153267A1 (en) | 2012-03-23 |
Family
ID=41721973
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11107246.4A HK1153267A1 (en) | 2008-08-29 | 2011-07-12 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
HK16100750.2A HK1212776A1 (zh) | 2008-08-29 | 2016-01-22 | 用於診斷和預後腎損傷和腎衰竭的方法和組合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16100750.2A HK1212776A1 (zh) | 2008-08-29 | 2016-01-22 | 用於診斷和預後腎損傷和腎衰竭的方法和組合物 |
Country Status (7)
Country | Link |
---|---|
US (2) | US9057735B2 (xx) |
EP (2) | EP2813848A3 (xx) |
JP (2) | JP5947544B2 (xx) |
CN (2) | CN102187219B (xx) |
CA (1) | CA2735590A1 (xx) |
HK (2) | HK1153267A1 (xx) |
WO (1) | WO2010025434A1 (xx) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0906858B8 (pt) | 2008-01-18 | 2021-07-27 | Harvard College | métodos in vitro para detectar a presença de uma célula de câncer em um indivíduo e para identificar uma assinatura específica de tumor em um indivíduo tendo câncer. |
AU2009285550B2 (en) * | 2008-08-28 | 2015-06-18 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2813848A3 (en) | 2008-08-29 | 2015-03-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN102246035B (zh) | 2008-10-21 | 2014-10-22 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
EP2347260A4 (en) * | 2008-10-21 | 2012-09-26 | Astute Medical Inc | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE |
AU2009313189B2 (en) | 2008-11-10 | 2014-10-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US20110229915A1 (en) * | 2008-11-22 | 2011-09-22 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US9229010B2 (en) | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN102576011B (zh) | 2009-08-07 | 2014-09-17 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的组合物和方法 |
CN102725635B (zh) | 2009-11-07 | 2015-05-20 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
CA2784889C (en) | 2009-12-20 | 2018-06-19 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US20120156701A1 (en) * | 2009-12-20 | 2012-06-21 | Joseph Anderberg | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
DK2666872T3 (en) | 2010-02-05 | 2016-07-25 | Astute Medical Inc | Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency |
NZ705411A (en) | 2010-02-26 | 2016-06-24 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2542697A4 (en) * | 2010-03-01 | 2013-09-11 | Astute Medical Inc | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE IN A NON-SURGICAL INTENSIVE CARE POPULATION |
ES2524082T3 (es) * | 2010-06-15 | 2014-12-04 | F.Hoffmann-La Roche Ag | Predicción y reconocimiento de la lesión renal aguda después de la cirugía |
AU2011269775B2 (en) | 2010-06-23 | 2015-01-15 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
IN2012MN02812A (xx) | 2010-06-23 | 2015-05-22 | Astute Medical Inc | |
AU2011280936A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
BR112013001752A2 (pt) | 2010-07-23 | 2016-05-31 | Harvard College | método de detectar doenças ou condições usando células fagocídicas |
CA2806296A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting kidney-associated diseases or conditions |
US20120053073A1 (en) | 2010-07-23 | 2012-03-01 | President And Fellows Of Harvard College | Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids |
EP2596116A4 (en) | 2010-07-23 | 2014-03-19 | Harvard College | METHODS FOR DETECTION OF AUTOIMMUNE OR IMMUNE-RELATED DISEASES / PATHOLOGIES |
US10557856B2 (en) * | 2010-09-24 | 2020-02-11 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Biomarkers of renal injury |
WO2012103450A2 (en) | 2011-01-29 | 2012-08-02 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
KR20140074307A (ko) * | 2011-08-26 | 2014-06-17 | 아스튜트 메디컬 인코포레이티드 | 신장 손상 및 신부전의 진단 및 예후진단을 위한 방법 및 조성물 |
EP3540440B1 (en) | 2011-12-08 | 2022-09-28 | Astute Medical, Inc. | Methods and uses for evaluating renal injury and renal status |
AU2013296231A1 (en) * | 2012-08-03 | 2015-03-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN107976547B (zh) | 2013-01-17 | 2020-08-25 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
EP2965086A4 (en) | 2013-03-09 | 2017-02-08 | Harry Stylli | Methods of detecting prostate cancer |
EP3410115A1 (en) * | 2013-05-14 | 2018-12-05 | Metabolon, Inc. | Tryptophan as a biomarkers for kidney function and methods using the same |
EP3077819A4 (en) | 2013-12-03 | 2017-06-28 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2016040843A1 (en) | 2014-09-11 | 2016-03-17 | Harry Stylli | Methods of detecting prostate cancer |
EP3281011B1 (en) | 2015-04-09 | 2024-06-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN106217377B (zh) * | 2015-10-14 | 2018-07-27 | 山东世纪元通智能科技有限公司 | 路径点式行走机器人的控制方法 |
EP3465201A4 (en) | 2016-06-06 | 2020-08-26 | Astute Medical, Inc. | MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR |
AU2018207151B2 (en) * | 2017-01-12 | 2024-02-29 | Astute Medical, Inc. | Methods and compositions for evaluation and treatment of renal injury and renal failure based on C-C motif chemokine ligand 14 measurement |
WO2018145117A1 (en) | 2017-02-06 | 2018-08-09 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN106845140A (zh) * | 2017-03-01 | 2017-06-13 | 重庆工商大学 | 一种基于尿比重和尿量监测的肾衰竭预警方法及系统 |
US11263275B1 (en) * | 2017-04-03 | 2022-03-01 | Massachusetts Mutual Life Insurance Company | Systems, devices, and methods for parallelized data structure processing |
US20180322956A1 (en) | 2017-05-05 | 2018-11-08 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Time Window-Based Platform for the Rapid Stratification of Blunt Trauma Patients into Distinct Outcome Cohorts |
AU2019272960A1 (en) | 2018-05-24 | 2020-12-10 | Renibus Therapeutics, Inc. | Methods of treating patients at risk for renal injury and renal failure |
WO2020064995A1 (en) * | 2018-09-28 | 2020-04-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of biomarkers representing cardiac, vascular and inflammatory pathways for the prediction of acute kidney injury in patients with type 2 diabetes |
CN109754878B (zh) * | 2018-11-30 | 2023-06-20 | 平安科技(深圳)有限公司 | 慢性肾病筛查方法、装置、设备及存储介质 |
CU24626B1 (es) * | 2019-12-26 | 2022-11-07 | Centro Nac De Biopreparados | Composición farmacéutica a base de proteínas con actividad neuroprotectora, inmunomoduladora, antiinflamatoria y antimicrobiana |
CN114783607B (zh) * | 2022-05-10 | 2023-06-23 | 中南大学湘雅医院 | 一种手术输血风险预测模型及其网络计算器的构建方法 |
CN118216609B (zh) * | 2024-05-24 | 2024-08-09 | 潍坊新希望六和饲料科技有限公司 | 一种多肽在降低羔羊断奶应激反应的饲料添加剂中的应用 |
Family Cites Families (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1429031A1 (ru) | 1986-06-20 | 1988-10-07 | Калининский Государственный Медицинский Институт | Способ дифференциальной диагностики гломерулонефрита и пиелонефрита |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
JPH05504841A (ja) | 1990-09-14 | 1993-07-22 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途 |
US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
DE69228682T2 (de) | 1991-04-10 | 1999-07-01 | Biosite Diagnostics Inc., San Diego, Calif. | "crosstalk"- oder übersprech-inhibitoren und ihre verwendung |
WO1992018866A1 (en) | 1991-04-10 | 1992-10-29 | Biosite Diagnostics Incorporated | Novel conjugates and assays for simultaneous detection of multiple ligands |
US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
DE69735364T3 (de) | 1996-05-24 | 2010-05-06 | Biogen Idec Ma Inc., Cambridge | Modulatoren für die regenerierung von gewebe |
US5753455A (en) | 1996-09-03 | 1998-05-19 | Bayer Corporation | Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid |
US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
JP2002512524A (ja) | 1997-06-03 | 2002-04-23 | 財団法人相模中央化学研究所 | 膜貫通ドメインを有するヒト蛋白質及びそれをコードするdna |
US20060223077A1 (en) | 1997-06-06 | 2006-10-05 | Human Genome Sciences, Inc. | 207 human secreted proteins |
US6218122B1 (en) | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
US6958147B1 (en) | 1998-10-26 | 2005-10-25 | Licentia Ltd | Use of VEGF-C to prevent restenosis |
MXPA01006404A (es) | 1998-12-21 | 2003-06-06 | Univ Monash | Deteccion y tratamiento de enfermedad renal. |
JP3869722B2 (ja) * | 1999-11-08 | 2007-01-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 細胞死の検出方法及び検出試薬 |
RU2180965C1 (ru) | 2000-07-03 | 2002-03-27 | Габбасова Наталья Вадимовна | Способ дифференциальной диагностики заболеваний почек |
WO2002054081A2 (en) | 2000-12-29 | 2002-07-11 | Oxford Glycosciences (Uk) Limited | Proteins, genes and their use for diagnosis and treatment of kidney response |
WO2002079411A2 (en) | 2001-03-29 | 2002-10-10 | Van Andel Institute | Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification |
JP3896303B2 (ja) * | 2001-05-09 | 2007-03-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | チトクロムc測定によるsirsにおける多臓器不全の検査試薬 |
US20070015146A1 (en) * | 2001-05-22 | 2007-01-18 | Gene Logic, Inc. | Molecular nephrotoxicology modeling |
US7235358B2 (en) | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
US20030003588A1 (en) | 2001-06-28 | 2003-01-02 | Comper Wayne D. | Method for kidney disease detection by protein profiling |
CN100516878C (zh) * | 2001-07-12 | 2009-07-22 | 协和美帝克斯股份有限公司 | 变性脂蛋白的定量方法及定量用试剂 |
EP1418813A4 (en) | 2001-07-24 | 2009-03-04 | Univ Yale | METHODS, COMPOSITIONS AND NEEDS RELATING TO CHITINASE AND CHITINASE MOLECULES AND INFLAMMATORY DISEASES |
US6784154B2 (en) | 2001-11-01 | 2004-08-31 | University Of Utah Research Foundation | Method of use of erythropoietin to treat ischemic acute renal failure |
US8404229B2 (en) | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
GB0130557D0 (en) | 2001-12-20 | 2002-02-06 | Serono Internat S A | Proteins |
WO2003075016A1 (en) | 2002-03-07 | 2003-09-12 | Cambridge University Technical Services Limited (Cuts) | Scd fingerprints |
WO2003081201A2 (en) | 2002-03-21 | 2003-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same |
US7138229B2 (en) | 2002-12-06 | 2006-11-21 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
US7138230B2 (en) | 2002-12-06 | 2006-11-21 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
AU2003281287A1 (en) | 2002-07-04 | 2004-01-23 | Oxford Glycosciences (Uk) Ltd | Toxicity markers |
US6941172B2 (en) | 2002-11-18 | 2005-09-06 | Zvi Nachum | Method and device for restoring kidney function using electromagnetic stimulation |
WO2004053074A2 (en) | 2002-12-06 | 2004-06-24 | Science And Technology Corporation @ Unm | Outcome prediction and risk classification in childhood leukemia |
CN1791797A (zh) | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
AU2004229501B2 (en) | 2003-04-11 | 2011-08-18 | Medimmune, Llc | Recombinant IL-9 antibodies and uses thereof |
WO2005002416A2 (en) | 2003-06-04 | 2005-01-13 | Joslin Diabetes Center, Inc. | Predictors of renal disease |
US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
GB0329288D0 (en) | 2003-12-18 | 2004-01-21 | Inverness Medical Switzerland | Monitoring method and apparatus |
CA2560200A1 (en) | 2004-03-17 | 2005-09-22 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Cd44-targeting for reducing/preventing ischemia-reperfusion-injury |
US20060204951A1 (en) | 2004-04-26 | 2006-09-14 | Judah Folkman | Platelet biomarkers for the detection of disease |
US20050272101A1 (en) | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
US7588892B2 (en) | 2004-07-19 | 2009-09-15 | Entelos, Inc. | Reagent sets and gene signatures for renal tubule injury |
US20080038192A1 (en) | 2004-07-19 | 2008-02-14 | Neurochem Inc. | Diagnostic Methods Of Multiple Organ Amyloidosis |
ES2788699T3 (es) * | 2004-08-30 | 2020-10-22 | Ipsen Biopharmaceuticals Inc | Procedimiento y dispositivo para diagnosticar y tratar trastornos de deficiencia del factor de crecimiento similar a la insulina |
US7141382B1 (en) | 2004-10-12 | 2006-11-28 | Parikh Chirag R | Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality |
AU2006210794A1 (en) | 2005-02-01 | 2006-08-10 | Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services | Biomarkers for tissue status |
EP2604703B1 (en) | 2005-03-14 | 2017-02-01 | The Board of Trustees of the Leland Stanford Junior University | Methods for evaluating graft survival in a solid organ transplant recipient |
US7608413B1 (en) | 2005-03-25 | 2009-10-27 | Celera Corporation | Kidney disease targets and uses thereof |
US20070037232A1 (en) | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
EP2339032B1 (en) * | 2005-04-18 | 2016-12-28 | MDNA Life Sciences Inc. | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
US20070087387A1 (en) | 2005-04-21 | 2007-04-19 | Prasad Devarajan | Method for the Early Detection of Renal Disease Using Proteomics |
US7833732B2 (en) | 2005-07-21 | 2010-11-16 | The John Hopkins University | Acute renal injury |
US7759077B2 (en) | 2005-08-02 | 2010-07-20 | Shariat Shahrokh F | Soluble fas urinary marker for the detection of bladder transitional cell carcinoma |
EP1757940A1 (en) | 2005-08-26 | 2007-02-28 | Cézanne S.A.S. | In vitro method for diagnosing and monitoring renal cell carcinoma (RCC) using MMP-7 as humoral biomarker for RCC |
AU2006299417A1 (en) | 2005-10-03 | 2007-04-12 | Biosite Incorporated | Methods and compositions for diagnosis and/or prognosis in Systemic Inflammatory Response Syndromes |
US20080090304A1 (en) * | 2006-10-13 | 2008-04-17 | Barasch Jonathan Matthew | Diagnosis and monitoring of chronic renal disease using ngal |
US8329408B2 (en) | 2005-10-31 | 2012-12-11 | Bayer Healthcare Llc | Methods for prognosis and monitoring cancer therapy |
US10716749B2 (en) | 2005-11-03 | 2020-07-21 | Palo Alto Investors | Methods and compositions for treating a renal disease condition in a subject |
US20080133141A1 (en) | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
TW200726845A (en) | 2006-01-02 | 2007-07-16 | Nat Defense Medical Ct | Biomarker molecular of renal illness and detecting method for the same |
GB0605217D0 (en) | 2006-03-15 | 2006-04-26 | Novartis Ag | Method and compositions for assessing acute rejection |
GB0606776D0 (en) | 2006-04-03 | 2006-05-10 | Novartis Pharma Ag | Predictive biomarkers for chronic allograft nephropathy |
US7662578B2 (en) | 2006-04-21 | 2010-02-16 | Children's Hospital Medical Center | Method and kit for the early detection of impaired renal status |
US20080038269A1 (en) | 2006-05-25 | 2008-02-14 | Mount Sinai Hospital | Methods for detecting and treating kidney disease |
WO2008084331A2 (en) | 2006-06-21 | 2008-07-17 | Hopitaux Universitaires De Geneve | Biomarkers for renal disorders |
WO2008005375A2 (en) | 2006-06-30 | 2008-01-10 | Merck & Co., Inc. | Kidney toxicity biomarkers |
WO2008009132A1 (en) | 2006-07-21 | 2008-01-24 | The Governors Of The University Of Alberta | Tissue rejection |
GB0617429D0 (en) | 2006-09-05 | 2006-10-18 | Electrophoretics Ltd | Markers of renal transplant rejection and renal damage |
US20080206794A1 (en) | 2006-09-15 | 2008-08-28 | Renovar Incorporated | Systems And Methods For Characterizing Contrast Induced-Nephropathy |
WO2008060607A2 (en) | 2006-11-14 | 2008-05-22 | Biosite Incorporated | Methods and compositions for monitoring and risk prediction in cardiorenal syndrome |
EP2064550B1 (en) * | 2006-12-08 | 2015-02-25 | The Children's Hospital Of Philadelphia | Use of prrg4 in methods of tumor diagnosis |
JP5162751B2 (ja) * | 2007-01-17 | 2013-03-13 | 国立大学法人 宮崎大学 | 急性腎不全の検出方法 |
GB0701626D0 (en) * | 2007-01-22 | 2007-03-07 | Cambridge Entpr Ltd | Methods and biomarkers for diagnosing and monitoring psychotic disorders |
EP1952823A1 (en) * | 2007-01-30 | 2008-08-06 | AM-Pharma B.V. | The use of alkaline phosphatase in the treatment of reduced renal function |
WO2008104803A2 (en) | 2007-02-26 | 2008-09-04 | Oxford Genome Sciences (Uk) Limited | Proteins |
US8221995B2 (en) | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
CA2681792A1 (en) | 2007-03-26 | 2008-10-02 | Novartis Ag | Predictive renal safety biomarkers and biomarker signatures to monitor kidney function |
CA2682538A1 (en) | 2007-04-10 | 2008-10-16 | Integragen | Human diabetes susceptibility tnfrsf10b gene |
US8080394B2 (en) * | 2007-04-27 | 2011-12-20 | Brigham And Women's Hospital | Method for determining predisposition to pulmonary infection |
US9091695B2 (en) | 2007-06-01 | 2015-07-28 | Laboratory Corporation Of America Holdings | Methods and systems for quantification of peptides and other analytes |
EP2160478B1 (en) | 2007-06-06 | 2014-08-27 | Siemens Healthcare Diagnostics Inc. | Predictive diagnostics for kidney disease |
US20090047689A1 (en) | 2007-06-20 | 2009-02-19 | John Kolman | Autoantigen biomarkers for early diagnosis of lung adenocarcinoma |
US20100267041A1 (en) | 2007-09-14 | 2010-10-21 | Predictive Biosciences, Inc. | Serial analysis of biomarkers for disease diagnosis |
US8039227B2 (en) | 2007-09-20 | 2011-10-18 | University Of Louisville Research Foundation, Inc. | Peptide biomarkers predictive of renal function decline and kidney disease |
US20110059537A1 (en) | 2007-09-20 | 2011-03-10 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Method for estimating risk of acute kidney injury |
US8003333B2 (en) | 2007-09-28 | 2011-08-23 | Mayo Foundation For Medical Education And Research | Serum biomarkers for early detection of acute cellular rejection |
JP4423375B2 (ja) | 2008-02-29 | 2010-03-03 | 国立大学法人名古屋大学 | 急性腎障害及び予後推定用バイオマーカー並びにその用途 |
US20090298106A1 (en) | 2008-05-30 | 2009-12-03 | Therapeutic Monitoring Services, L.L.C. | Methods for Monitoring Immunosuppressant Drug Levels, Renal Function, and Hepatic Function Using Small Volume Samples |
US8241861B1 (en) * | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
US7998744B2 (en) * | 2008-07-28 | 2011-08-16 | Greenwood Genetic Center, Inc. | Methods for determining dysregulation of methylation of brain expressed genes on the X chromosome to diagnose autism spectrum disorders |
WO2010022210A2 (en) | 2008-08-21 | 2010-02-25 | Pxbiosciences Llc | Diagnosis and monitoring of renal failure using peptide biomarkers |
AU2009285550B2 (en) | 2008-08-28 | 2015-06-18 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2813848A3 (en) | 2008-08-29 | 2015-03-11 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US8501489B2 (en) | 2008-09-26 | 2013-08-06 | University of Pittsburgh—of the Commonwealth System of Higher Education | Urinary biomarkers to predict long-term dialysis |
EP2347260A4 (en) | 2008-10-21 | 2012-09-26 | Astute Medical Inc | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE |
CN102246035B (zh) | 2008-10-21 | 2014-10-22 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
AU2009313189B2 (en) | 2008-11-10 | 2014-10-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2394166B1 (en) | 2009-02-06 | 2016-07-13 | Astute Medical, Inc. | Methods for diagnosis and prognosis of renal injury and failure |
US9229010B2 (en) | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
MX2011008323A (es) * | 2009-02-06 | 2011-09-21 | Astute Medical Inc | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. |
AU2010230855A1 (en) | 2009-04-03 | 2012-01-12 | Vegenics Limited | Anti-VEGF-D antibodies |
ES2656232T3 (es) | 2009-05-08 | 2018-02-26 | Novartis Ag | Métodos de modulación de fibrosis usando moduladores de la proteína morfogenética ósea 9 (BMP-9) |
US20110065598A1 (en) | 2009-08-07 | 2011-03-17 | Rules-Based Medicine, Inc. | Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders |
US20120190044A1 (en) | 2009-09-21 | 2012-07-26 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CA2784889C (en) | 2009-12-20 | 2018-06-19 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US20130035290A1 (en) | 2011-05-17 | 2013-02-07 | Yale University | Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury |
-
2009
- 2009-08-28 EP EP14176863.0A patent/EP2813848A3/en not_active Withdrawn
- 2009-08-28 JP JP2011525262A patent/JP5947544B2/ja not_active Expired - Fee Related
- 2009-08-28 WO PCT/US2009/055460 patent/WO2010025434A1/en active Application Filing
- 2009-08-28 US US13/061,446 patent/US9057735B2/en not_active Expired - Fee Related
- 2009-08-28 CN CN200980140694.6A patent/CN102187219B/zh not_active Expired - Fee Related
- 2009-08-28 EP EP09810705.5A patent/EP2324354B1/en not_active Not-in-force
- 2009-08-28 CN CN201510400587.XA patent/CN105021826A/zh active Pending
- 2009-08-28 CA CA2735590A patent/CA2735590A1/en not_active Abandoned
-
2011
- 2011-07-12 HK HK11107246.4A patent/HK1153267A1/xx not_active IP Right Cessation
-
2015
- 2015-06-14 US US14/738,904 patent/US9417250B2/en not_active Expired - Fee Related
- 2015-11-30 JP JP2015233652A patent/JP2016053587A/ja active Pending
-
2016
- 2016-01-22 HK HK16100750.2A patent/HK1212776A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN102187219A (zh) | 2011-09-14 |
JP2016053587A (ja) | 2016-04-14 |
EP2324354A1 (en) | 2011-05-25 |
JP5947544B2 (ja) | 2016-07-06 |
CN105021826A (zh) | 2015-11-04 |
US20110174062A1 (en) | 2011-07-21 |
EP2324354A4 (en) | 2012-03-21 |
US9057735B2 (en) | 2015-06-16 |
HK1212776A1 (zh) | 2016-06-17 |
US20150285824A1 (en) | 2015-10-08 |
US9417250B2 (en) | 2016-08-16 |
EP2324354B1 (en) | 2014-07-16 |
CN102187219B (zh) | 2015-08-05 |
JP2012501457A (ja) | 2012-01-19 |
EP2813848A2 (en) | 2014-12-17 |
EP2813848A3 (en) | 2015-03-11 |
CA2735590A1 (en) | 2010-03-04 |
WO2010025434A1 (en) | 2010-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212776A1 (zh) | 用於診斷和預後腎損傷和腎衰竭的方法和組合物 | |
HK1213320A1 (zh) | 用於診斷和預後腎損傷和腎衰竭的方法和組合物 | |
HK1203619A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1199929A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1199931A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1211082A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1159755A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
EP2480882A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL LESIONS AND FAILURES | |
HK1208074A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1167455A1 (zh) | 用於腎損傷和腎衰竭的診斷及預後方法和組合物 | |
HK1214864A1 (zh) | 用於腎損傷和腎衰竭的診斷及預後的方法和組合物 | |
EP2539712A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
HK1200218A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
EP2531620A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
HK1167888A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1211084A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1212774A1 (zh) | 用於腎損傷和腎衰竭的診斷及預後方法和組合物 | |
EP2462446A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency | |
EP2531622A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
EP2585825A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE | |
EP2531621A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency | |
EP2593794A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency | |
HK1197298A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180823 |